Check out our new site just for you: Campus Connection!

News Archive

Below you’ll find all of our archived press releases, articles written by the Crohn's & Colitis Foundation of America (CCFA), as well as research articles from external media sources. You can also search for a specific news item or topic by using direct keywords (for example, “CCFA research”) or by filtering the news by date or category.

Please note: If you are a member of the media interested in speaking with a CCFA spokesperson, contact us today.

Search News:

Senate Resolution 199 supports first Crohn’s and Colitis Awareness Week

December 1, 2011

The week of December 1-7 has been designated by the Crohn’s & Colitis Foundation of America (CCFA) as Crohn’s and Colitis Awareness Week in order to encourage all Americans to join in the effort to find cures for these diseases, help raise awareness and support research.

Do IBD Treatments Cause Cancer?

December 1, 2011

According to the newest data presented at the 2011 Advances in Inflammatory Bowel Diseases Crohn’s & Colitis Foundation’s Clinical & Research Conference, the benefits of treating Inflammatory Bowel Disease (IBD) with the latest therapies outweigh the slightly increased risk associated with cancer.

Panel of Experts to Examine Need for Expanded Research and Treatment Options

October 7, 2011

Congressional Crohn’s and Colitis Caucus Co-Chairmen Rep. Ander Crenshaw (R-FL) and Rep. Jesse Jackson, Jr., (D-IL) today (10/7) announced that the Caucus will hold its kick-off briefing on Wednesday, October 12.

Crohn's patients respond to J&J's Stelara in study

May 9, 2011

ohnson & Johnson's Stelara helped a significantly higher percentage of Crohn's disease sufferers than those who received a placebo, according to a study of patients who had not been helped by other commonly used drugs.

Safety Announcement Concerning TNF Blockers

April 14, 2011

The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma or HSTCL), primarily in adolescents and young adults being treated for Crohn's disease and ulcerative colitis with medicines known as tumor necrosis factor (TNF) blockers, as well as with azathioprine, and/or mercaptopurine.

Meta-analysis confirms efficacy of biological therapy for IBD

March 25, 2011

A meta-analysis of randomized controlled trials (RCTs) supports the use of FDA-approved biological therapies in patients with active Crohn's disease or ulcerative colitis who have failed first- and second-line therapy or who are dependent on corticosteroids, researchers report.

Accutane for Acne: Not Always the Best Medicine?

August 24, 2010

Acne isn't an exclusively teenage problem. It can afflict adults as well, and it's especially problematic among people with IBD taking steroid therapy, which can trigger or aggravate the distressing skin disorder.

Stress may be an IBD trigger

April 16, 2010

People with inflammatory bowel disease (IBD) commonly believe that stress can trigger their symptoms, and a new study suggests they may be right.

Finding the Funds for College

January 15, 2010

Are you thinking about college and concerned about its ever-rising costs? At CCFA, we understand the harsh impact of medical expenses on a family budget, but don't let fear of finances stop you from pursuing your educational ambitions to the max. You can certainly find ways to make college affordable, as long as you're prepared to do some serious homework.

Items 81 - 89 of 89  Previous12345